4.7 Review

Acute-on-chronic liver failure: far to go-a review

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Predicting the Onset of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

Jinjin Luo et al.

Summary: This study aimed to develop and validate a prognostic score to predict the onset of acute-on-chronic liver failure (ACLF) in patients with hepatitis B virus (HBV)-related chronic liver disease. The study identified four predictors (total bilirubin, international normalized ratio, alanine aminotransferase, and ferritin) that were significantly associated with ACLF onset at 7 days. The newly developed prognostic score showed higher predictive value compared to other existing scores.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

Emmanuel Weiss et al.

Summary: This study aimed to identify metabolites associated with short-term death in patients with acutely decompensated cirrhosis and design metabolomic prognostic models. Three prognostic metabolites strongly associated with death were selected and two models were built, which were found to be more accurate in predicting death within 7, 14, and 28 days compared to traditional scoring systems.
Article Health Care Sciences & Services

Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort study

Peng Li et al.

Summary: This study aimed to identify an appropriate score for predicting the survival benefit of liver transplantation (LT) in HBV-related acute-on-chronic liver failure (ACLF) patients. The results showed that the COSSH-ACLF IIs score accurately predicted the risk of death on the waitlist and post-LT mortality, and patients with a score of 7-10 derived a higher net survival benefit from LT.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2023)

Article Gastroenterology & Hepatology

Acute-on-Chronic Liver Failure Clinical Guidelines

Jasmohan S. Bajaj et al.

Summary: Acute-on-chronic liver failure is a major cause of mortality in patients with cirrhosis and chronic liver disease. These guidelines, representing the official practice recommendations of the American College of Gastroenterology, provide the preferred approach to the management of patients with acute-on-chronic liver failure.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Article Rheumatology

Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection

Zhenyu Zhong et al.

Summary: Patients with a time-weighted average prednisone dose greater than 20 mg/day may be classified as high risk for HBV reactivation or hepatitis flare, and prophylactic anti-HBV therapy may be needed for these high-risk patients.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Biochemistry & Molecular Biology

Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

Martin Guilliams et al.

Summary: This study presents a spatial proteogenomic atlas of the liver, combining multiple omics datasets, and reveals the cellular niches and transcriptomic identities of Kupffer cells and lipid-associated macrophages. It also demonstrates the inducibility of lipid-associated macrophages by local lipid exposure and the crucial role of ALK1-BMP9/10 axis in Kupffer cell development.
Article Gastroenterology & Hepatology

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF

Jiang Li et al.

Summary: This study suggests that immune-metabolism disorder triggered by HBV exacerbation may be a potential mechanism of HBV-ACLF, providing a novel diagnostic and treatment target to reduce HBV-ACLF-related mortality.
Review Gastroenterology & Hepatology

Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis

Gabriel Mezzano et al.

Summary: The study revealed high global prevalence and mortality rates of ACLF, with regional variations possibly explained by triggers/aetiology of CLD or grade.
Article Biology

Transcriptomics reveals immune-metabolism disorder in acute-on-chronic liver failure in rats

Hozeifa M. Hassan et al.

Summary: This study reveals the phenomenon of immune-metabolism disorder in ACLF rats based on transcriptomic analysis, providing clinicians with new targets for improving intervention strategies.

LIFE SCIENCE ALLIANCE (2022)

Letter Gastroenterology & Hepatology

G-CSF in acute-on-chronic liver failure - Art of 'patient selection' is paramount!

Ankur Jindal et al.

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure

Ingrid W. Zhang et al.

Summary: The study revealed severe mitochondrial dysfunction in leukocytes of patients with acute decompensated cirrhosis and ACLF, suggesting that mitochondrial abnormalities in body tissues may be a consequence of inadequate cell energy output.

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis

Adria Juanola et al.

Summary: This study found that in patients with decompensated cirrhosis, urinary L-FABP levels are independently associated with the 3-month clinical course and can predict mortality and ACLF development.

JOURNAL OF HEPATOLOGY (2022)

Article Cell Biology

Chloride intercellular channel 3 suppression-mediated macrophage polarization: a potential indicator of poor prognosis of hepatitis B virus-related acute-on-chronic liver failure

Jing Liang et al.

Summary: During the progression of HBV-related liver diseases, the polarization of macrophages gradually shifts from classical activation to alternative activation. The increase in the percentage of alternatively activated macrophages and the suppression of CLIC3 may serve as potential indicators for poor prognosis in patients with HBV-ACLF.

IMMUNOLOGY AND CELL BIOLOGY (2022)

Article Gastroenterology & Hepatology

Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF

Cornelius Engelmann et al.

Summary: The combination treatment of TAK-242 and G-CSF can reduce inflammation, promote liver regeneration, and prevent mortality in models of acute-on-chronic liver failure.

JOURNAL OF HEPATOLOGY (2022)

Article Genetics & Heredity

Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

William L. Hwang et al.

Summary: This study provides a high-resolution molecular landscape of pancreatic ductal adenocarcinoma (PDAC) using single-nucleus RNA sequencing and whole-transcriptome digital spatial profiling. It identifies recurrent expression programs in malignant cells and fibroblasts, including a newly identified neural-like progenitor malignant cell program associated with poor prognosis. The study also reveals three multicellular communities with distinct contributions from malignant, fibroblast and immune subtypes. This refined molecular and cellular classification can guide clinical trials and therapeutic targeting for specific cellular phenotypes and multicellular interactions.

NATURE GENETICS (2022)

Article Gastroenterology & Hepatology

A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation

Xueyun Zhang et al.

Summary: The study found a relationship between the COSSH-ACLF grades of HBV-ACLF patients at 3-7 days after diagnosis and the final confirmation. For patients with poor prognosis, urgent liver transplantation may improve survival rates; however, the necessity of liver transplantation for patients with good prognosis remains unclear.

DIGESTIVE DISEASES AND SCIENCES (2021)

Article Gastroenterology & Hepatology

Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure

Florence Wong et al.

Summary: Bacterial infections can trigger acute-on-chronic liver failure, with varying rates and clinical characteristics in different geographic regions, particularly with the highest incidence in the Indian subcontinent.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF

Giacomo Zaccherini et al.

Summary: In patients with ACLF, metabolite modules increased along with markers of systemic inflammation and oxidative stress. Most proteinogenic amino acids were present and increased. A metabolic network involving amino acids was activated, suggesting increased nucleotide synthesis. Certain compounds involved in antioxidant synthesis were increased. Intermediates of ketogenic amino acids catabolism were increased. Levels of spermidine, an autophagy inducer, were decreased.

JOURNAL OF HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis

Vicente Arroyo et al.

Summary: Systemic inflammation may be a key feature of acute decompensation of cirrhosis, affecting organ system function through various mechanisms and working synergistically with traditional pathways to contribute to the development of AD. It can exacerbate splanchnic vasodilation by overactivating the endogenous vasoconstrictor systems, leading to hypoperfusion in certain vascular beds such as the renal circulation. Additionally, systemic inflammation may cause immune-mediated tissue damage and induce significant metabolic changes.

JOURNAL OF HEPATOLOGY (2021)

Article Immunology

Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF

Emmanuel Weiss et al.

Summary: Patients with ACLF exhibit dysregulation of blood immune cells, including increased neutrophils and M0-like monocytes, as well as depletion of various lymphocyte subsets. These immune cell alterations, along with defective neutrophil superoxide anion production, may contribute to immunosuppression in ACLF, highlighting potential targets for future therapies.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure

Wei Wu et al.

Summary: Patients with ACLF exhibit significant alterations in circulating neutrophils, including increased absolute neutrophil count and changes in phenotype, gene expression, and function. These alterations are associated with poor outcomes and influenced by the circulatory environment in ACLF. Inhibiting glycolysis can reverse neutrophil dysfunction in ACLF patients.

FRONTIERS IN IMMUNOLOGY (2021)

Article Gastroenterology & Hepatology

Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)

Luca S. Belli et al.

Summary: This study reveals significant variations in the listing of patients with ACLF in Europe despite favorable post-LT survival. Risk factors for post-LT mortality were identified, enabling a more precise prognostic assessment of patients with ACLF.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure

Jiaqi Li et al.

Summary: A new prognostic score based on six predictors was developed to accurately predict short-term mortality in patients with HBV-ACLF. This score outperformed four other commonly used scores in terms of predictive ability.

JOURNAL OF HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

New clinical and pathophysiological perspectives defining the trajectory of cirrhosis

Rajiv Jalan et al.

Summary: Traditionally, complications of cirrhosis were thought to be primarily caused by circulatory dysfunction due to portal hypertension; however, recent studies have shown that systemic inflammation and organ immunopathology play crucial roles in organ dysfunction in cirrhosis, impacting various organ systems. The interaction between traditional and emerging concepts in the initiation and maintenance of organ dysfunction in cirrhosis is a topic of great interest for future research.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Granulocyte-colony stimulating factor (G-CSF) to treat acute-on- chronic liver failure: A multicenter randomized trial (GRAFT study)

Cornelius Engelmann et al.

Summary: In this multicenter controlled trial, G-CSF did not show significant beneficial effects on ACLF patients compared to standard medical therapy alone. The study was terminated prematurely due to futility after analysis. Therefore, G-CSF should not be recommended as a standard treatment for ACLF.

JOURNAL OF HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Intensive care management of acute-on-chronic liver failure

William Bernal et al.

Summary: Acute-on-chronic liver failure syndrome involves liver function deterioration, extrahepatic organ failure, and high mortality rate, requiring rapid and coherent management in the intensive care unit to improve patient outcomes.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis

Joan Claria et al.

Summary: This study focused on blood lipidomics in cirrhosis patients, revealing a generalized suppression of lipids in circulation. Specific lipid fingerprints were identified for distinguishing AD and ACLF, with liver dysfunction and infections playing key roles in their dynamics. Moreover, blood lysophosphatidylcholine levels increased in patients after albumin therapy.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation

Frederik Nevens et al.

Summary: The study demonstrated the safety of treating patients with ACLF or AD with human allogeneic liver-derived progenitor cells within a certain dosage range and showed gradual improvement in systemic inflammation and liver function for the patients.

JHEP REPORTS (2021)

Review Gastroenterology & Hepatology

Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment

Giacomo Zaccherini et al.

Summary: ACLF is a life-threatening condition characterized by sudden worsening of clinical outcomes in patients with cirrhosis or chronic liver disease. Different definitions, diagnostic criteria, and treatments have been proposed, with supportive therapy and liver transplantation showing efficacy in managing ACLF. Future studies on mechanistic treatments to improve patient survival are needed.

JHEP REPORTS (2021)

Article Gastroenterology & Hepatology

Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice

Xiaogang Xiang et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure

Cornelius Engelmann et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure

Markus Trieb et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

Jonel Trebicka et al.

JOURNAL OF HEPATOLOGY (2020)

Review Medicine, General & Internal

Acute-on-Chronic Liver Failure

Vicente Arroyo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Gastroenterology & Hepatology

Burden of liver diseases in the world

Sumeet K. Asrani et al.

JOURNAL OF HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Acute-on-chronic liver failure in patients with alcohol-related liver disease

Thierry Gustot et al.

JOURNAL OF HEPATOLOGY (2019)

Review Critical Care Medicine

Artificial liver support in acute and acute-on-chronic liver failure

Fin Stolze Larsen

CURRENT OPINION IN CRITICAL CARE (2019)

Editorial Material Gastroenterology & Hepatology

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

Shiv Kumar Sarin et al.

HEPATOLOGY INTERNATIONAL (2019)

Article Gastroenterology & Hepatology

The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis

Thomas Serste et al.

JOURNAL OF HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Acute-on-chronic liver failure in chronic hepatitis B: an update

Rui-Hong Zhao et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Liver transplantation in patients with multiple organ failures: Feasibility and outcomes

Paul J. Thuluvath et al.

JOURNAL OF HEPATOLOGY (2018)

Letter Gastroenterology & Hepatology

Prevalent acute-on-chronic liver failure and response to corticosteroids in alcoholic hepatitis

Ewan H. Forrest et al.

JOURNAL OF HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension

Dinesh Mani Tripathi et al.

GASTROENTEROLOGY (2018)

Review Critical Care Medicine

Emerging Role of Extracorporeal Support in Acute and Acute-on-Chronic Liver Failure: Recent Developments

Andrew J. MacDonald et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Article Cell Biology

Deregulation of Regulatory T Cells in Acute-on-Chronic Liver Failure: A Rat Model

Shunlan Ni et al.

MEDIATORS OF INFLAMMATION (2017)

Article Critical Care Medicine

Current Evidence for Extracorporeal Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure

Constantine J. Karvellas et al.

CRITICAL CARE CLINICS (2016)

Article Gastroenterology & Hepatology

Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B

Jang-June Park et al.

GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis

Mark J. W. McPhail et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Management of the critically ill patient with cirrhosis: A multidisciplinary perspective

Mitra K. Nadim et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

A model of acute kidney injury in mice with cirrhosis and infection

Daniel E. Carl et al.

LIVER INTERNATIONAL (2016)

Article Gastroenterology & Hepatology

Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis

Thierry Gustot et al.

HEPATOLOGY (2015)

Review Gastroenterology & Hepatology

Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis

Norberto C. Chavez-Tapia et al.

ANNALS OF HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Survival in Infection-Related Acute-on-Chronic Liver Failure Is Defined by Extrahepatic Organ Failures

Jasmohan S. Bajaj et al.

HEPATOLOGY (2014)

Review Gastroenterology & Hepatology

Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance

Agustin Albillos et al.

JOURNAL OF HEPATOLOGY (2014)

Article Biochemistry & Molecular Biology

Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2

Alastair J. O'Brien et al.

NATURE MEDICINE (2014)

Review Gastroenterology & Hepatology

Liver support strategies: cutting-edge technologies

Benjamin Struecker et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

Review Immunology

Immune surveillance by the liver

Craig N. Jenne et al.

NATURE IMMUNOLOGY (2013)

Article Gastroenterology & Hepatology

Management of critically-ill cirrhotic patients

Pere Ginès et al.

JOURNAL OF HEPATOLOGY (2012)

Article Cell & Tissue Engineering

Human Mesenchymal Stem Cell Transfusion Is Safe and Improves Liver Function in Acute-on-Chronic Liver Failure Patients

Ming Shi et al.

STEM CELLS TRANSLATIONAL MEDICINE (2012)

Review Critical Care Medicine

Acute-on-chronic liver failure: extracorporeal liver assist devices

Tarek I. Hassanein et al.

CURRENT OPINION IN CRITICAL CARE (2011)

Review Medicine, General & Internal

Current Concepts: Management of Varices and Variceal Hemorrhage in Cirrhosis.

Guadalupe Garcia-Tsao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Gastroenterology & Hepatology

Artificial and bioartificial liver devices: present and future

B. Carpentier et al.

Review Medicine, General & Internal

MEDICAL PROGRESS Alcoholic Hepatitis

Michael R. Lucey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Gastroenterology & Hepatology

In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separation

P Krisper et al.

JOURNAL OF HEPATOLOGY (2005)

Article Gastroenterology & Hepatology

Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B

RG van der Molen et al.

HEPATOLOGY (2004)

Review Infectious Diseases

Immunology of hepatitis B infection

MC Jung et al.

LANCET INFECTIOUS DISEASES (2002)